TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883), a pioneering company developing innovative products for the treatment of rare genetic diseases ...
The renewal highlights ongoing progress in developing rhLAM-111 for rare muscular diseases, with a new emphasis on Duchenne Muscular Dystrophy. We are excited to have renewed our EU Orphan Drug ...
Hosted on MSN
Muscle regeneration hindered by missing protein in rare muscular dystrophy, study shows
For more than two decades, researchers at the University of Basel, Switzerland, have been investigating a severe form of muscular dystrophy in which muscles progressively degenerate. The research team ...
Duchenne muscular dystrophy (DMD) is a rare neurological condition that causes severe muscle weakness and intellectual disability. DMD is an inherited (passed down) disorder. The condition is linked ...
Congenital muscular dystrophy is a severe muscle-wasting disease that is often caused by mutations in LAMA2, the gene encoding the laminin α2 chain expressed by muscle fibres. In September 20 Nature, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback